Responses to ragweed pollen in a pollen challenge chamber versus seasonal exposure identify allergic rhinoconjunctivitis endotypes.

[1]  M. Kraft.  Asthma phenotypes and interleukin-13--moving closer to personalized medicine. , 2011, The New England journal of medicine.

[2]  Nicola A Hanania,et al.  Lebrikizumab treatment in adults with asthma. , 2011, The New England journal of medicine.

[3]  R. Jacobs,et al.  Validation of the biogenics research chamber for Juniperus ashei (mountain cedar) pollen. , 2011, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[4]  N. Krug,et al.  Anti-allergic drug testing in an environmental challenge chamber is suitable both in and out of the relevant pollen season. , 2011, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[5]  T. Holland-Letz,et al.  Diagnostic value of outcome measures following allergen exposure in an environmental challenge chamber compared with natural conditions , 2010, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[6]  A. Day,et al.  Factors that affect the allergic rhinitis response to ragweed allergen exposure. , 2010, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[7]  M. Danzig,et al.  Onset of action of loratadine/montelukast in seasonal allergic rhinitis subjects exposed to ragweed pollen in the Environmental Exposure Unit. , 2009, Allergy and asthma proceedings.

[8]  K. Hashiguchi,et al.  Validation Study of the OHIO Chamber in Patients with Japanese Cedar Pollinosis , 2009, International Archives of Allergy and Immunology.

[9]  R. Garadi,et al.  Onset and duration of action of nasal sprays in seasonal allergic rhinitis patients: olopatadine hydrochloride versus mometasone furoate monohydrate. , 2007, Allergy and asthma proceedings.

[10]  S. Melamed,et al.  Skin test results and self‐reported symptom severity in allergic rhinitis: the role of psychological factors , 2006, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[11]  O. Cromwell,et al.  Giant ragweed specific immunotherapy is not effective in a proportion of patients sensitized to short ragweed: analysis of the allergenic differences between short and giant ragweed. , 2005, The Journal of allergy and clinical immunology.

[12]  M. Andersson,et al.  Clinical trial design, nasal allergen challenge models, and considerations of relevance to pediatrics, nasal polyposis, and different classes of medication. , 2005, The Journal of allergy and clinical immunology.

[13]  J. Weiler,et al.  Onset of action, efficacy, and safety of fexofenadine 60 mg/pseudoephedrine 120 mg versus placebo in the Atlanta allergen exposure unit. , 2002, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[14]  J. H. Day,et al.  Environmental exposure unit: a system to test anti-allergic treatment. , 1999, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[15]  S. Rønborg,et al.  Exposure chamber for allergen challenge The development and validation of a new concept , 1996, Allergy.

[16]  M. Andersson,et al.  Allergen‐induced nasal hyperreactivity appears unrelated to the size of the nasal and dermal immediate allergic reaction , 1987, Allergy.

[17]  K. Mathews,et al.  Priming of the nasal mucosa by ragweed extract or by an irritant (ammonia). , 1981, The Journal of allergy and clinical immunology.

[18]  G. Gleich,et al.  The cross-reactivity of IgE antibodies with pollen allergens. II. Analyses of various species of ragweed and other fall weed pollens. , 1976, The Journal of allergy and clinical immunology.

[19]  G. Gleich,et al.  The cross-reactivity of IgE antibodies with pollen allergens. I. Analyses of various species of grass pollens. , 1976, The Journal of allergy and clinical immunology.

[20]  I. Bernstein,et al.  In vitro cross-allergenicity of major aeroallergenic pollens by the radioallergosorbent technique. , 1976, The Journal of allergy and clinical immunology.